Beck, EJ; Miners, AH; Tolley, K; (2001) The cost of HIV treatment and care. A global review. PharmacoEconomics, 19 (1). pp. 13-39. ISSN 1170-7690 DOI: https://doi.org/10.2165/00019053-200119010-00002 Full text not available from this repository.

Beutels, P; Edmunds, WJ; Antonanzas, F; de Wit, GA; Evans, D; Feilden, R; Fendrick, AM; Ginsberg, GM; Glick, HA; Mast, E; +3 more... Pechevis, M; van Doorslaer, EK; van Hout, BA; (2002) Economic evaluation of vaccination programmes: a consensus statement focusing on viral hepatitis. PharmacoEconomics, 20 (1). pp. 1-7. ISSN 1170-7690 DOI: https://doi.org/10.2165/00019053-200220010-00001 Full text not available from this repository.

Cheung, YB; Thumboo, J; (2006) Developing Health-Related Quality-of-Life Instruments for Use in Asia: The Issues. PharmacoEconomics, 24 (7). pp. 643-50. ISSN 1170-7690 DOI: https://doi.org/10.2165/00019053-200624070-00003 Full text not available from this repository.

Dowie, J; (2005) No room for kinkiness in a public healthcare system. PharmacoEconomics, 23 (12). pp. 1203-5. ISSN 1170-7690 DOI: https://doi.org/10.2165/00019053-200523120-00004 Full text not available from this repository.

Gheorghe, A; Roberts, T; Hemming, K; Calvert, M; (2015) Evaluating the Generalisability of Trial Results: Introducing a Centre- and Trial-Level Generalisability Index. PharmacoEconomics, 33 (11). pp. 1195-1214. ISSN 1170-7690 DOI: https://doi.org/10.1007/s40273-015-0298-3 Full text not available from this repository.

Hoomans, T; Severens, JL; van der Roer, N; Delwel, GO; (2012) Methodological quality of economic evaluations of new pharmaceuticals in The Netherlands. PharmacoEconomics, 30 (3). pp. 219-27. ISSN 1170-7690 DOI: https://doi.org/10.2165/11539850-000000000-00000 Full text not available from this repository.

Ishak, KJ; Kreif, N; Benedict, A; Muszbek, N; (2013) Overview of Parametric Survival Analysis for Health-Economic Applications. PharmacoEconomics, 31 (8). pp. 663-675. ISSN 1170-7690 DOI: https://doi.org/10.1007/s40273-013-0064-3 Full text not available from this repository.

Karnon, J; Vanni, T; (2011) Calibrating Models in Economic Evaluation A Comparison of Alternative Measures of Goodness of Fit, Parameter Search Strategies and Convergence Criteria. PharmacoEconomics, 29 (1). pp. 51-62. ISSN 1170-7690 DOI: https://doi.org/10.2165/11584610-000000000-00000 Full text not available from this repository.

Miners, A; (2008) Estimating 'costs' for cost-effectiveness analysis. PharmacoEconomics, 26 (9). pp. 745-51. ISSN 1170-7690 DOI: https://doi.org/10.2165/00019053-200826090-00005 Full text not available from this repository.

Miners, AH; Sabin, CA; Tolley, KH; Lee, CA; (2002) Cost-utility analysis of primary prophylaxis versus treatment on-demand for individuals with severe haemophilia. PharmacoEconomics, 20 (11). pp. 759-74. ISSN 1170-7690 DOI: https://doi.org/10.2165/00019053-200220110-00005 Full text not available from this repository.

Miners, AH; Yao, G; Raftery, J; Taylor, RS; (2007) Economic evaluations of calcineurin inhibitors in renal transplantation: a literature review. PharmacoEconomics, 25 (11). pp. 935-47. ISSN 1170-7690 DOI: https://doi.org/10.2165/00019053-200725110-00004 Full text not available from this repository.

Newall, AT; Jit, M; Beutels, P; (2012) Economic evaluations of childhood influenza vaccination: a critical review. PharmacoEconomics, 30 (8). pp. 647-60. ISSN 1170-7690 DOI: https://doi.org/10.2165/11599130-000000000-00000 Full text not available from this repository.

Newall, AT; Jit, M; Hutubessy, R; (2014) Are current cost-effectiveness thresholds for low- and middle-income countries useful? Examples from the world of vaccines. PharmacoEconomics, 32 (6). pp. 525-31. ISSN 1170-7690 DOI: https://doi.org/10.1007/s40273-014-0162-x Full text not available from this repository.

Newall, AT; Jit, M; Hutubessy, R; (2014) Authors' Reply to Gandjour: "Are Current Cost-Effectiveness Thresholds for Low- and Middle-Income Countries Useful? Examples from the World of Vaccines". PharmacoEconomics, 32 (12). p. 1247. ISSN 1170-7690 DOI: https://doi.org/10.1007/s40273-014-0232-0 Full text not available from this repository.

Pacini, M; Smith, RD; Wilson, EC; Holland, R; (2007) Home-based medication review in older people: is it cost effective? PharmacoEconomics, 25 (2). pp. 171-80. ISSN 1170-7690 DOI: https://doi.org/10.2165/00019053-200725020-00008 Full text not available from this repository.

Petrillo, J; van Nooten, F; Jones, P; Rutten-van Mölken, M; (2011) Utility estimation in chronic obstructive pulmonary disease: a preference for change? PharmacoEconomics, 29 (11). pp. 917-32. ISSN 1170-7690 DOI: https://doi.org/10.2165/11589280-000000000-00000 Full text not available from this repository.

Robberstad, B; Cairns, J; (2007) Time preferences for health in northern Tanzania : an empirical analysis of alternative discounting models. PharmacoEconomics, 25 (1). pp. 73-88. ISSN 1170-7690 DOI: https://doi.org/10.2165/00019053-200725010-00007 Full text not available from this repository.

Sach, TH; Smith, RD; Whynes, DK; (2007) A 'league table' of contingent valuation results for pharmaceutical interventions: a hard pill to swallow? PharmacoEconomics, 25 (2). pp. 107-27. ISSN 1170-7690 DOI: https://doi.org/10.2165/00019053-200725020-00004 Full text not available from this repository.

Setiawan, D; Wondimu, A; Ong, K; van Hoek, AJ; Postma, MJ; (2018) Cost Effectiveness of Human Papillomavirus Vaccination for Men Who have Sex with Men; Reviewing the Available Evidence. PharmacoEconomics. ISSN 1170-7690 DOI: https://doi.org/10.1007/s40273-018-0649-y Full text not available from this repository.

Shillcutt, SD; Walker, DG; Goodman, CA; Mills, AJ; (2009) Cost Effectiveness in Low- and Middle-Income Countries A Review of the Debates Surrounding Decision Rules. PharmacoEconomics, 27 (11). pp. 903-917. ISSN 1170-7690 DOI: https://doi.org/10.2165/10899580-000000000-00000 Full text not available from this repository.

Tantivess, S; Teerawattananon, Y; Mills, A; (2009) Strengthening Cost-Effectiveness Analysis in Thailand through the Establishment of the Health Intervention and Technology Assessment Program. PharmacoEconomics, 27 (11). pp. 931-945. ISSN 1170-7690 DOI: https://doi.org/10.2165/11314710-000000000-00000 Full text not available from this repository.

Vanni, T; Karnon, J; Madan, J; White, RG; Edmunds, WJ; Foss, AM; Legood, R; (2011) Calibrating models in economic evaluation: a seven-step approach. PharmacoEconomics, 29 (1). pp. 35-49. ISSN 1170-7690 DOI: https://doi.org/10.2165/11584600-000000000-00000 Full text not available from this repository.

Welte, R; Trotter, CL; Edmunds, WJ; Postma, MJ; Beutels, P; (2005) The role of economic evaluation in vaccine decision making: focus on meningococcal group C conjugate vaccine. PharmacoEconomics, 23 (9). pp. 855-74. ISSN 1170-7690 DOI: https://doi.org/10.2165/00019053-200523090-00001 Full text not available from this repository.

Carvalho, N; Jit, M; Cox, S; Yoong, J; Hutubessy, RCW; (2017) Capturing Budget Impact Considerations Within Economic Evaluations: A Systematic Review of Economic Evaluations of Rotavirus Vaccine in Low- and Middle-Income Countries and a Proposed Assessment Framework. PharmacoEconomics. ISSN 1170-7690 DOI: https://doi.org/10.1007/s40273-017-0569-2

Faria, R; Gomes, M; Epstein, D; White, IR; (2014) A Guide to Handling Missing Data in Cost-Effectiveness Analysis Conducted Within Randomised Controlled Trials. PharmacoEconomics, 32 (12). pp. 1157-1170. ISSN 1170-7690 DOI: https://doi.org/10.1007/s40273-014-0193-3

Jit, M; Brisson, M; (2011) Modelling the epidemiology of infectious diseases for decision analysis: a primer. PharmacoEconomics, 29 (5). pp. 371-86. ISSN 1170-7690 DOI: https://doi.org/10.2165/11539960-000000000-00000

Laurence, YV; Griffiths, UK; Vassall, A; (2015) Costs to Health Services and the Patient of Treating Tuberculosis: A Systematic Literature Review. PharmacoEconomics, 33 (9). pp. 939-55. ISSN 1170-7690 DOI: https://doi.org/10.1007/s40273-015-0279-6

Leurent, B; Gomes, M; Faria, R; Morris, S; Grieve, R; Carpenter, JR; (2018) Sensitivity Analysis for Not-at-Random Missing Data in Trial-Based Cost-Effectiveness Analysis: A Tutorial. PharmacoEconomics. ISSN 1170-7690 DOI: https://doi.org/10.1007/s40273-018-0650-5

Leurent, Baptiste; Gomes, Manuel; Faria, Rita; Morris, Stephen; Grieve, Richard; Carpenter, James R; (2019) Correction to: Sensitivity Analysis for Not-at-Random Missing Data in Trial-Based Cost-Effectiveness Analysis: A Tutorial. PharmacoEconomics. ISSN 1170-7690 DOI: https://doi.org/10.1007/s40273-019-00776-7

Thom, H; Jackson, C; Welton, N; Sharples, L; (2017) Erratum to: Using Parameter Constraints to Choose State Structures in Cost-Effectiveness Modelling. Springer Verlag. DOI: https://doi.org/10.1007/s40273-017-0520-6

Thom, H; Jackson, C; Welton, N; Sharples, L; (2017) Using Parameter Constraints to Choose State Structures in Cost-Effectiveness Modelling. PharmacoEconomics. ISSN 1170-7690 DOI: https://doi.org/10.1007/s40273-017-0501-9

Ultsch, B; Damm, O; Beutels, P; Bilcke, J; Brüggenjürgen, B; Gerber-Grote, A; Greiner, W; Hanquet, G; Hutubessy, R; Jit, M; +10 more... Knol, M; von Kries, R; Kuhlmann, A; Levy-Bruhl, D; Perleth, M; Postma, M; Salo, H; Siebert, U; Wasem, J; Wichmann, O; (2015) Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community. PharmacoEconomics. ISSN 1170-7690 DOI: https://doi.org/10.1007/s40273-015-0335-2

Leurent, B; Gomes, M; Carpenter, J; (2018) Comment on: Sensitivity Analysis for Not-at-Random Missing Data in Trial-Based Cost-Effectiveness Analysis: A Tutorial. PharmacoEconomics. ISSN 1170-7690 DOI: https://doi.org/10.1007/s40273-018-0700-z Item availability may be restricted.